GovChime
Notice ID: 010433029e1a4011974c2d94143193c2Combined Synopsis/Solicitation

FDA/CDRH/OCE COMPREHENSIVE INTERNAL COMMUNICATIONS ASSESSMENT

Archived on October 4, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM UTC−04:00
Posted
September 13, 2023
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
541611: Administrative Management and General Management Consulting Services
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Last updated
Sep 9, 2025

Identifiers

Solicitation number
FDA-SOL-23-1267862
Notice ID
010433029e1a4011974c2d94143193c2

Description

***This RFQ has been amended via Amendment 1 to update "Attachment A FAR 52.212-5 Contract Terms and Conditions Required To Implement Statutes or Executive Orders Commercial Products and Commercial Services (SEP 2023) (Updated)," and to add a new attachment titled, "Attachment C Questions and Answers." In addition, the RFQ document has been amended for the following reasons: to incorporate FAR provisions and clauses in effect through Federal Acquisition Circular (FAC) 2023-05, effective September 7, 2023; to incorporate FAR 52.212-3 Offeror Representations and Certifications Commercial Products and Commercial Services (SEP 2023); to incorporate FAR 52.212-5 Contract Terms and Conditions Required To Implement Statutes or Executive Orders Commercial Items (SEP 2023); to remove language on Organizational Conflicts of Interests; to correct a website address; and to make minor formatting and heading revisions. Please note that the deadline for submitting quotes has NOT been extended. *** In accordance with the attached Request for Quotation (RFQ) no. FDA-SOL-23-1267862, the Government anticipates awarding one (1) Firm-Fixed-Price (FFP) type Purchase Order. The anticipated Period of Performance (PoP) is the 12-month period following the date of award, anticipated to commence on September 25, 2023. The actual PoP will be determined at time of award.The objective of this Purchase Order is to procure a comprehensive internal communications assessment performed off-premises (remotely) in support of the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Communication and Education (OCE). This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6- Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This is Request for Quotation (RFQ) no. FDA-SOL-23-1267862 for commercial services in accordance with the procedures of FAR Part 12- Acquisition of Commercial Products and Commercial Services, and FAR Part 13- Simplified Acquisition Procedures. The associated North American Industry Classification System (NAICS) code is 541611- Administrative Management and General Management Consulting Services. The associated small business size standard is $24.5 million.This is a total small business set-aside solicitation in accordance with FAR Subpart 19.5.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:FDA-SOL-23-1267862
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentSep 6, 2023

    FDA/CDRH/OCE COMPREHENSIVE INTERNAL COMMUNICATIONS ASSESSMENT

    Notice 010433029e1a4011974c2d94143193c2 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Please refer to revised documents and questions and answers before submitting your proposal. New due date 09 November 2026. Walter Reed National Military Medical Center (WRNMMC) has a requirement for non-personal services to support the Hospital Communications Department and Executive Secretary Program. The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform Hospital Communications and Executive Secretariat Support Services as defined in this Performance Work Statement (PWS) except for those items specified as government furnished property and services.
-Solicitation11/09/2026
FOOD AND DRUG ADMINISTRATION (FDA) Regulatory Support Services BPA SOURCES SOUGHT NOTICE (SSN) Description The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Regulatory Support Services. THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to contact any of the respondents after the submission deadline if additional information is required. The purpose of this SSN is to identify and gain knowledge of potential business sources and small business sources that are capable of providing the full range of services described in this SSN and the attached Draft Statement of Work (SOW). Responses to this SSN will be utilized for a potential solicitation for an anticipated stand-alone BPA for Regulatory Support Services Program. The anticipated period of performance for this contract is a Fiscal Year 2027 award with a base year, plus four (4) option years), with a potential 6-month extension of services pursuant to FAR 52.217-8. Requested Information Interested parties are highly encouraged to respond to this SSN by providing the following information in their response: Completed Vendor Feedback Form – See attached Vendor Feedback Form If applicable, tracked changes/comments on draft SOW in MS Word format – See attached Draft SOW Capability Statement Responses shall be submitted via email with the subject line "Sources Sought Notice - FDA SSN: CTP-2027-136871” to the Contracting Officer, Nicholas Bisher (Nicholas.Bisher@fda.hhs.gov), no later than 5:00pm (Eastern) on November 24, 2026. Attachments Vendor Feedback Form Draft Statement of Work
-Market Research11/24/2026
The purpose of this requirement is to provide customer service and program operations support for the NPDB program, which will include web content development, general Call Center and email support to the NPDB users on all NPDBrelated issues, questions, or concerns, NPDB program operations support, and outreach.
-Sole Source / J&AOpen
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Quotation (RFQ) or a promise to issue an RFQ in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFQ, if issued. The purpose of this SSN is to gain knowledge of potential qualified vendors, including large business sources, small business sources and their size classifications (i.e., HUBZone 8(a), 8(a), HUBZone, Service-Disabled Veteran-Owned, Veteran-Owned, Women-Owned Small Business, and Small Disadvantaged Business) relative to the North American Industry Classification System (NAICS) code. Responses to this SSN will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA/CDRH Scientific Technical Capacity for Regulatory Review Background: To assist the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) in fulfilling its mission, CDRH seeks expert consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle. CDRH requires consultants that have skilled experience to assist with medical device regulatory review work and supporting scientific activities, such as research, cybersecurity and digital health consultations, regulatory consultations and auditing, and interacting with industry and patients. The CDRH requires consultants that have sufficient skilled capacity in many science, engineering, and clinical specialties, including Anesthesiology, Biology, Biomedical Engineering, Chemistry, Clinical laboratory testing, Computer Science and Engineering, Consumer Safety, Cybersecurity, Data Science, Dentistry, Digital Health, Epidemiology, Gastroenterology, General Engineering, Health Science, Infectious Diseases, Interdisciplinary Engineer/Scientist, Molecular testing, Neurology, Optics, Patient Engagement, Physics, Psychiatry, Public Health, Pulmonology, Reprocessing medical devices, Social Scientist, Software Engineering, Statistics and Biostatistics, Sterilization, Toxicology, Urology, Veterinary Medicine, and Virology. Objective: The primary objective of this effort is to provide the CDRH with a vehicle to acquire the support services of advanced professional and scientific consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle, including the supporting scientific, engineering, clinical, and regulatory activities. The services provided will be critical scientific expertise and capacity in support for the evaluation of the continued performance, safety, and effectiveness, with respect to devices approved, cleared, licensed, or authorized for use for the treatment, prevention, or diagnosis of medical conditions by the FDA. Instructions for Responses to this SSN: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). The anticipated period of performance consists of one (1) Base Year and four (4) Option Years. Responses to this SSN must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Does your firm qualify as a Small Disadvantaged Business? If disadvantaged, specify if your firm is certified under Section 8(a) of the Small Business Act? Are you considered a certified HUBZone firm? Are you considered Woman-Owned or operated business? Are you a certified Service-Disabled Veteran-Owned or Veteran-Owned business? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (“Attachment A-Draft Statement of Work”). All interested parties can provide written opinions/questions on the draft Statement of Work. All opinions/questions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Responses to this SSN shall be submitted via e-mail to Melinda Kim, Contract Specialist, at Melinda.Kim@fda.hhs.gov, (with a CC: to Nicholas Bisher, Contracting Officer, at Nicholas.Bisher@fda.hhs.gov), by 2:00 PM Eastern Standard Time on November 17, 2026. The subject line of the e-mail shall reference, “Vendor Response to SSN 75F40127Q00006.” After a review of the received responses, a formal solicitation may be published on SAM.gov or on GSA eBuy. No solicitation is currently available. This is not a request for quotation and in no way obligates the Government to award any contract. Responses to this SSN will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Attachments: Attachment A-Draft Statement of Work Attachment B-Vendor Feedback Form
-Market Research11/17/2026
This a combined Request for Information (RFI) and Sources Sought Notice (SSN) issued solely for market research and acquisition planning purposes for the CICP requirement. In an effort to reach the widest audience, this Notice may be cross posted on other Government buying platforms such as GSA eBuy or others. This Notice is not a solicitation, Request for Proposal, Invitation for Bids, or commitment by the Government to issue a solicitation or award a contract. Responses are voluntary. The Government will not reimburse respondents for costs associated with preparing or submitting a response. Respondents should clearly identify proprietary information. HRSA is conducting market research under RFO Part 10 to support acquisition planning for Countermeasures Injury Compensation (CICP) Reconsideration Panel Support Services. The current requirement is fulfilled under a Time-and-Materials (T&M) contract No. 75R60223D00002. For the purposes of this notice HRSA is seeking industry and small business feedback to: Understand the types of businesses including small businesses who are capable of fulfilling the requirement. For small businesses, this notice seeks to specifically identify capable 8a, HUBZone, SDVOSBs, WOSB and other small businesses. Assess the feasibility of transitioning some or all of these services to a performance-based Firm-Fixed-Price (FFP) structure , consistent with Executive Order 14402, Promoting Efficiency, Accountability, and Performance in Federal Contracting, dated April 30, 2026, which establishes fixed-price contracts with performance-based considerations as the default and preferred method of Federal procurement, to the maximum extent consistent with law. This Notice seeks industry feedback regarding whether the requirement, in whole or in part, is sufficiently defined to permit realistic FFP pricing and reasonable allocation of performance and cost risk. HRSA also seeks feedback regarding alternative or hybrid contract structures where FFP may not be appropriate for portions of the requirement, as well as performance measures, pricing methodology, workload assumptions, transition requirements, and small business capability. Obtain general feedback on the CICP requirement. The Government may use the information received to refine the acquisition strategy, Performance Work Statement (PWS), Independent Government Cost Estimate (IGCE), Quality Assurance Surveillance Plan (QASP), and any future solicitation. The Government is seeking sufficient information to support these acquisition-planning decisions and is not requesting proposals at this time.
-Market Research12/04/2026

Additional Details

Solicitation Number

FDA-SOL-23-1267862

Archive Date

Oct 4, 2023

Office Address

Beltsville, MD, 20705